2013 Top Ten

Dec 18, 2013

ACC News Story

Font Size
A
A
A
Jump to Top 10: News Stories | Journal Scans | Clinical Trials | Advocacy Headlines | Practice Management Headlines | ACC in Touch Blog Posts | Community Headlines
 
2013 Top Ten

From new prevention guidelines to practice-changing clinical trials, and even a bi-partisan conversation on the ACC in Touch Blog about a single-payer health care system, 2013 has been a busy one for the ACC.

The College has compiled a series of top 10 lists — giving you the most talked about, interesting or important content for cardiovascular professionals this year on CardioSource.org. Take a look at the top news stories, Journal Scans, Clinical Trials, Advocacy and Practice Management content, and blog posts in 2013.
Top 10 News Stories
Top 10 Journal Scans
Top 10 Clinical Trials
Top 10 Advocacy Headlines
Top 10 Practice Management Headlines
Top 10 Community Headlines
  1. EHRA Practical Guide on the Use of New Oral Anticoagulants (Afib Community)
  2. Management and Outcomes of Major Bleeding During Treatment
    (Anticoagulation Management Community)
  3. The Basics of Biomarkers
    (Cardiac Biomarkers Community)
  4. A 63-Year-Old Man With STEMI and Muscle Cramps Wants to Reduce His Statin Dose
    (Cardiometabolic Disease Community)
  5. Fractional Flow Reserve Guided vs. Angiography Guided (Chronic Angina Community)
  6. POTS Diagnosis and Treatment: Basics and New Developments
    (Cardiac Rhythm Management Community)
  7. The Basics of Sleep Apnea and Heart Failure (Sleep Apnea and CVD Community)
  8. Case Challenge: A 62-Year-Old Male With High Cholesterol and Occasional Chest Pressure (Chronic Angina Community)
  9. ARISTOTLE Trial and the Recent FDA Approval of Apixaban (AFib Community)
  10. What Are the Differences Between NT-proBNP and BNP and do They Matter?
    (Cardiac Biomarkers Community)
Top 10 ACC in Touch Blog Posts

Keywords: Morpholines, Overweight, Ticlopidine, Lobbying, Cholesterol, beta-Alanine, Biomarkers, Benzimidazoles, International Classification of Diseases, Outpatients, Obesity, Pyridones, Medicare, Heart Valves, Natriuretic Peptide, Brain, Carbamates, Cost-Benefit Analysis, Stroke, National Heart, Lung, and Blood Institute (U.S.), Mitral Valve Insufficiency, Piperazines, Pyrazoles, Sleep Apnea Syndromes, Heart Failure, Fee Schedules, Muscle Cramp, Biomedical Research


< Back to Listings